BLACK DIAMOND THERAPEUTICS I's ticker is BDTX and the CUSIP is 09203E105. A total of 86 filers reported holding BLACK DIAMOND THERAPEUTICS I in Q1 2022. The put-call ratio across all filers is 15.47 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $706 | -98.4% | 246 | -97.1% | 0.00% | – |
| Q2 2023 | $43,021 | +596.2% | 8,519 | +148.2% | 0.00% | – |
| Q4 2022 | $6,179 | -31.3% | 3,433 | -36.1% | 0.00% | – |
| Q3 2022 | $9,000 | -79.5% | 5,375 | -69.5% | 0.00% | – |
| Q2 2022 | $44,000 | -24.1% | 17,599 | -15.5% | 0.00% | – |
| Q1 2022 | $58,000 | -63.1% | 20,820 | -29.6% | 0.00% | – |
| Q4 2021 | $157,000 | +9.8% | 29,554 | +75.7% | 0.00% | – |
| Q3 2021 | $143,000 | +2.9% | 16,821 | +48.0% | 0.00% | – |
| Q2 2021 | $139,000 | -86.7% | 11,367 | -73.7% | 0.00% | – |
| Q1 2021 | $1,048,000 | +17366.7% | 43,189 | +21823.4% | 0.00% | – |
| Q3 2020 | $6,000 | -96.9% | 197 | -95.8% | 0.00% | – |
| Q2 2020 | $196,000 | +8.9% | 4,654 | -35.6% | 0.00% | – |
| Q1 2020 | $180,000 | – | 7,231 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEA Management Company, LLC | 3,449,845 | $110,568,000 | 2.92% |
| Boxer Capital, LLC | 2,014,858 | $64,576,000 | 2.08% |
| RA Capital Management | 2,589,904 | $83,006,000 | 1.16% |
| Artal Group S.A. | 1,646,517 | $52,771,000 | 1.13% |
| Burrage Capital Management LLC | 34,891 | $1,118,000 | 0.85% |
| Bellevue Group AG | 1,403,000 | $44,967,000 | 0.52% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 802,511 | $25,720,000 | 0.51% |
| Ikarian Capital, LLC | 293,941 | $9,421,000 | 0.42% |
| Avoro Capital Advisors LLC | 640,000 | $20,512,000 | 0.35% |
| Logos Global Management LP | 123,465 | $3,957,000 | 0.34% |